Compositions useful as inhibitors of GSK-3

Details Compositions useful as inhibitors of GSK-3 Compositions useful as inhibitors of GSK-3

2003-08-01

2009-02-17

Balasubram, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S234500, C514S252180, C514S256000, C544S328000, C544S122000, C544S060000, C544S295000

Reexamination Certificate

active

07491730

ABSTRACT:
The present invention provides a compound of formula I:or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3 mammalian protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

REFERENCES:
patent: 3133081 (1964-05-01), Lafferty et al.
patent: 3755322 (1973-08-01), Winter et al.
patent: 3935183 (1976-01-01), Baron et al.
patent: 3998951 (1976-12-01), Harnish et al.
patent: 4051252 (1977-09-01), Mayer et al.
patent: 4493726 (1985-01-01), Burdeska et al.
patent: 4540968 (1985-09-01), Ishkawa et al.
patent: 4711951 (1987-12-01), Axen et al.
patent: 5124441 (1992-06-01), Carlsson et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6093716 (2000-07-01), Davis et al.
patent: 6184226 (2001-02-01), Chakravarty et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6495582 (2002-12-01), Hale et al.
patent: 6528509 (2003-03-01), Hale et al.
patent: 6558657 (2003-05-01), Mandeville, III et al.
patent: 6562971 (2003-05-01), Frauenkron et al.
patent: 6579983 (2003-06-01), Batchelor et al.
patent: 6589958 (2003-07-01), Frietze
patent: 6610677 (2003-08-01), Davies et al.
patent: 6613776 (2003-09-01), Knegtel et al.
patent: 6638926 (2003-10-01), Davies et al.
patent: 6653300 (2003-11-01), Bebbington et al.
patent: 6653301 (2003-11-01), Bebbington et al.
patent: 6656939 (2003-12-01), Bebbington et al.
patent: 6660731 (2003-12-01), Bebbington et al.
patent: 6664247 (2003-12-01), Bebbington et al.
patent: 6696452 (2004-02-01), Davies et al.
patent: 6727251 (2004-04-01), Bebbington et al.
patent: 6841579 (2005-01-01), Plowman et al.
patent: 6846928 (2005-01-01), Bebbington et al.
patent: 6989385 (2006-01-01), Bebbington et al.
patent: 7008948 (2006-03-01), Bebbington et al.
patent: 7087603 (2006-08-01), Bebbington et al.
patent: 7091343 (2006-08-01), Bebbington et al.
patent: 7098330 (2006-08-01), Bebbington et al.
patent: 7115739 (2006-10-01), Bebbington et al.
patent: 7179826 (2007-02-01), Bebbington et al.
patent: 2001/0018436 (2001-08-01), Cushing et al.
patent: 2002/0052386 (2002-05-01), Armistead et al.
patent: 2002/0065270 (2002-05-01), Moriarty et al.
patent: 2003/0004161 (2003-01-01), Bebbington et al.
patent: 2003/0004164 (2003-01-01), Bebbington et al.
patent: 2003/0022885 (2003-01-01), Bebbington et al.
patent: 2003/0036543 (2003-02-01), Bebbington et al.
patent: 2003/0055044 (2003-03-01), Davies et al.
patent: 2003/0055068 (2003-03-01), Bebbington et al.
patent: 2003/0064981 (2003-04-01), Knegtel et al.
patent: 2003/0064982 (2003-04-01), Davies et al.
patent: 2003/0069239 (2003-04-01), Cai et al.
patent: 2003/0069248 (2003-04-01), Chakravarty et al.
patent: 2003/0073687 (2003-04-01), Bebbington et al.
patent: 2003/0078166 (2003-04-01), Davies et al.
patent: 2003/0078275 (2003-04-01), Bebbington et al.
patent: 2003/0083327 (2003-05-01), Davies et al.
patent: 2003/0087922 (2003-05-01), Bethiel et al.
patent: 2003/0092714 (2003-05-01), Cao et al.
patent: 2003/0096813 (2003-05-01), Cao et al.
patent: 2003/0096816 (2003-05-01), Cao et al.
patent: 2003/0105090 (2003-06-01), Bebbington et al.
patent: 2003/0144309 (2003-07-01), Choon-Moon
patent: 2003/0171389 (2003-09-01), Bemis et al.
patent: 2003/0187002 (2003-10-01), Mortlock et al.
patent: 2003/0199526 (2003-10-01), Choquetta et al.
patent: 2003/0207873 (2003-11-01), Harrington et al.
patent: 2003/0225073 (2003-12-01), Bebbington et al.
patent: 2004/0002496 (2004-01-01), Bebbington et al.
patent: 2004/0009974 (2004-01-01), Bebbington et al.
patent: 2004/0009981 (2004-01-01), Bebbington et al.
patent: 2004/0009996 (2004-01-01), Moon et al.
patent: 2004/0023963 (2004-02-01), Cao et al.
patent: 2004/0029857 (2004-02-01), Hale et al.
patent: 2004/0097501 (2004-05-01), Bebbington et al.
patent: 2004/0097531 (2004-05-01), Ledeboer et al.
patent: 2004/0157893 (2004-08-01), Bebbington et al.
patent: 2004/0214814 (2004-10-01), Bebbington et al.
patent: 2004/0229875 (2004-11-01), Cao et al.
patent: 2005/0004110 (2005-01-01), Bebbington et al.
patent: 2005/0038023 (2005-02-01), Bebbington et al.
patent: 2005/0234059 (2005-10-01), Hale et al.
patent: 2006/0270660 (2006-11-01), Charrier et al.
patent: 2458965 (1976-06-01), None
patent: 0019811 (1980-12-01), None
patent: 136976 (1985-04-01), None
patent: 0302312 (1989-02-01), None
patent: 2052487 (1981-01-01), None
patent: 10-130150 (1998-05-01), None
patent: 2000-26421 (2000-01-01), None
patent: 06-65237 (2007-10-01), None
patent: 9208715 (1992-05-01), None
patent: WO 93/22681 (1993-11-01), None
patent: 9509851 (1995-04-01), None
patent: 9515758 (1995-06-01), None
patent: WO 95/15758 (1995-06-01), None
patent: 9709325 (1997-03-01), None
patent: 9719065 (1997-05-01), None
patent: 9802434 (1998-01-01), None
patent: WO 98/02434 (1998-01-01), None
patent: 9811095 (1998-03-01), None
patent: 9816502 (1998-04-01), None
patent: WO 98/14450 (1998-04-01), None
patent: 9918781 (1999-04-01), None
patent: 9941253 (1999-08-01), None
patent: 9947154 (1999-09-01), None
patent: 9965897 (1999-12-01), None
patent: WO 99/62518 (1999-12-01), None
patent: 0012497 (2000-03-01), None
patent: WO 00/21955 (2000-04-01), None
patent: 0038675 (2000-07-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/42029 (2000-07-01), None
patent: 0059509 (2000-10-01), None
patent: 0078757 (2000-12-01), None
patent: 0112621 (2001-02-01), None
patent: 0125220 (2001-04-01), None
patent: 0139777 (2001-06-01), None
patent: 0140215 (2001-06-01), None
patent: 0144242 (2001-06-01), None
patent: 0147879 (2001-07-01), None
patent: WO 01/60816 (2001-08-01), None
patent: 0164655 (2001-09-01), None
patent: WO 01/79198 (2001-10-01), None
patent: WO 02/18346 (2002-03-01), None
patent: WO 02/22601 (2002-03-01), None
patent: 0250066 (2002-06-01), None
patent: WO 02/50065 (2002-06-01), None
patent: 0279197 (2002-10-01), None
patent: 0224667 (2003-03-01), None
patent: 0247690 (2003-06-01), None
patent: WO 03/049739 (2003-06-01), None
patent: 0400833 (2003-12-01), None
patent: 0413140 (2004-02-01), None
patent: 9614843 (2008-07-01), None
Duhe et al. Cell Biochem. Biophys. 34(1): 17-59, 2001.
Rane et al., Oncogene 19(49): 5662-79, 2000.
Kim et al., Curr. Opin Genet Dev. 10(5): 508-514, 2000.
Gary W. Cline et al, “Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimluated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats”, Diabetes, 51: 2903-2910 (2002).
Erik J. Henriksen et al, “Modulation of Muscle Insulin Resistance by Selective Inhibition of GSK-3 in Zucker Diabetic Fatty Rats”, American Journal of Physiology Endocrinology and Metabolism, 284: E892-E900 (2003).
Medwid, J.B., et al., “Preparation of Triazolo[1,5-c] pyrimidines as Potential Antiasthma Agents”,J. Med. Chem., 33:1230-1241 (1990).
Traxler, P., et al., “Use of Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: Phenylamino)pyrazole [3,4-d]pyrimidines”,J. Med. Chem., 40:3601-3616 (1997).
Parnell, E.W., “2-Cyano-4-nitrophenylhydrazine and 3-Amino-5-nitroindazole”,J. Chem. Soc., 2363-2365 (1959).
Partridge, M. W., et al., “Cyclic Amidines, Part XXII.1Novel Isomerism of Disubstituted Tri-cycloquinazolines and Molecular Orientations in Carcinogenesis”,J. Chem. Soc., 19:2641-2647 (1970).
Baig, G. U., et al., “Triazines and Related Products. Part 271. Thermolysis of 4-Anilino-1,2,3-benzotriazines”,J. Chem. Soc. Perkin Trans. 1(5):999-1003 (1984).
Ivashchenko, A. V. et al: “Synthesis and study of heteroaromatic ligands containing a pyrimidine ring” Khim. Geterotsikyl. Soedin. (12) 1673-7 (1980).
Traxler, P.Exp. Opin. Ther. Targets7(2):215-234 (2003).
Haq, S. et al., “Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy”, J. Cell Biol., 151(1), 117-129 (2000).
Fischer, P.M. et al., “Inhibitors of Cyclin-

Affiliated with

Also associated with

Rating

Compositions useful as inhibitors of GSK-3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions useful as inhibitors of GSK-3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of GSK-3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4096188